Profile photo Mirjam Geerlings

Mirjam Geerlings

Associate Professor

Strategic program(s):

Biography

I received my MSc degree in Neuropsychology and PhD degree in Epidemiology from the VU medical center Amsterdam, the Netherlands. From 2000 until 2002, I worked as a post-doc at the Department of Epidemiology & Biostatistics of the Erasmus Medical Center, Rotterdam where I studied steroid hormones as risk factors for dementia using data from the Rotterdam Study. From 2002 until 2022, I worked at the Julius Center for Health Sciences and Primary Care (University Medical Center Utrecht), first as Assistant Professor, and since 2006 as Associate Professor where I initiated, conducted, and supervised research within the department of Epidemiology. I also developed, coordinated and taught epidemiology courses within the Biomedical Sciences (BSc), Medicine (BSc and MSc), and MSc Epidemiology curriculum. I supervised around 40 MSc and BSc students during their research and completing their MSc or BSc thesis. Additionally, I mentored a substantial number of research assistants, PhD candidates, and postdoctoral fellows. I am a PI of the research programs Circulatory Health (research theme Cerebrovascular disease) and Brain within the UMC Utrecht. 

Since May 2022, I am head of the section Research and member of the management team of the department of General Practice at Amsterdam UMC. Since January 2023, I am affiliated with the Julius Center (UMC Utrecht) as a guest researcher.

Within the UMC Utrecht, I lead the SMART-MR study, a sub-study of the UCC-SMART study. The SMART-MR study (SMART-MR study) is an ongoing prospective cohort study among 1309 non-demented, independently living middle-aged to older adults with manifest arterial disease, aimed to investigate determinants and consequences of brain changes on MRI, including depression and cognitive decline. Individuals were assessed at up to three visits: at baseline, 4 years, and 12 years follow-up. I am also PI of the Medea 7T study, a cohort study in the UMC Utrecht, aimed to investigate determinants and consequences of microstructural brain abnormalities on 7 tesla brain MRI. With the UCC-SMART study and SMART-MR study I participate in national and international consortia, including the Netherlands Consortium for Dementia Cohorts (NCDC), the Psychosocial factors and cancer incidence (PSY-CA) consortium, and the CHARGE consortium. Starting in 2023, I also participate in the BIRD-NL consortium.

Internationally, I have longstanding collaborations with the Laboratory of Epidemiology and Population Sciences, National Institute on Aging, USA (dr. Lenore Launer) where I published using data from the Honolulu Asia Aging Study and the AGES-Reykjavik Study.

 

Research line

Epidemiology of cerebrovascular disease and brain health.

 

Publications

in PubMed:

geerlings mi OR (geerlings m AND (gerritsen OR nazareth)) OR (ggeerlings mi AND Scarth M AND Vonk JM AND Gerritsen L) - Search Results - PubMed (nih.gov)

 

Recent publications

Psychosocial and cognitive determinants of 10-year depressive symptom trajectories in patients with cardiovascular disease Emma L. Twait, Annelot P. Smit, Magdalena Beran, Ina Rissanen, Mirjam I. Geerlings,
Journal of Affective Disorders, 2025, vol. 373, p.196-202
Identifying pathways to the prevention of dementia Julie E Oomens, Justine E F Moonen, Stephanie J B Vos, Magdalena Beran, Pedro Mateus, Peter P De Deyn, Wiesje M van der Flier, Mirjam I Geerlings, Martijn A Huisman, M Arfan Ikram, Miranda T Schram, P Eline Slagboom, W M Monique Verschuren, Marian Beekman, Iñigo Bermejo, Mahlet Birhanu, Esther E Bron, Andre Dekker, Ingeborg Frentz, Swier J F Garst, Eva Jaarsma, Almar A L Kok, Sofia Marcolini, Leon Mei, Eric P Moll van Charante, Edo Richard, Casper G Schalkwijk, Thomas T van Sloten, Charlotte E Teunissen, Emma L Twait, Inge M W Verberk, Jet M J Vonk, Marjo P H van de Waarenburg, Frank J Wolters, Willemijn J Jansen, Pieter Jelle Visser
BMC Neurology, 2025, vol. 25
Development and external validation of the SMA2SH2ERS risk prediction model for aneurysmal subarachnoid haemorrhage in the general population Vita M. Klieverik, Jos P. Kanning, Ina L. Rissanen, Kristiina Rannikmae, Amy E. Martinsen, Bendik S. Winsvold, Mirjam I. Geerlings, Ynte M. Ruigrok
BMJ Open, 2025, vol. 15
Sex differences in modifiable risk factors for stroke incidence and recurrence Ina Rissanen, Maartje Basten, Lieza G Exalto, Sanne A E Peters, Frank L J Visseren, Mirjam I Geerlings,
Journal of Neurology, 2024, vol. 271, p.3347-3358
Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence Jos P Kanning, Shahab Abtahi, Christian Schnier, Olaf H Klungel, Mirjam I Geerlings, Ynte M Ruigrok
Neurology, 2024, vol. 102
Depression and dementia Lotte Gerritsen, Emma L. Twait, Palmi V. Jonsson, Vilmundur Gudnason, Lenore J. Launer, Mirjam I. Geerlings
2024, p.620-632